0001181431-13-043445.txt : 20130807
0001181431-13-043445.hdr.sgml : 20130807
20130807191109
ACCESSION NUMBER: 0001181431-13-043445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130806
FILED AS OF DATE: 20130807
DATE AS OF CHANGE: 20130807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IPC The Hospitalist Company, Inc.
CENTRAL INDEX KEY: 0001410471
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 954562058
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4605 LANKERSHIM BLVD., SUITE 617
CITY: NORTH HOLLYWOOD
STATE: CA
ZIP: 91602
BUSINESS PHONE: 818-766-3502
MAIL ADDRESS:
STREET 1: 4605 LANKERSHIM BLVD., SUITE 617
CITY: NORTH HOLLYWOOD
STATE: CA
ZIP: 91602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singer Adam D MD
CENTRAL INDEX KEY: 0001424032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33930
FILM NUMBER: 131019505
MAIL ADDRESS:
STREET 1: C/O IPC THE HOSPITALIST COMPANY, INC.
STREET 2: 4605 LANKERSHIM BLVD SUITE 617
CITY: NORTH HOLLYWOOD
STATE: CA
ZIP: 91602
4
1
rrd387785.xml
FORM 4 - ADAM SINGER 8.6.2013
X0306
4
2013-08-06
0
0001410471
IPC The Hospitalist Company, Inc.
IPCM
0001424032
Singer Adam D MD
C/O IPC THE HOSPITALIST COMPANY, INC.
4605 LANKERSHIM BLVD., STE 617
NORTH HOLLYWOOD
CA
91602
1
1
0
0
CEO & Chairman
Common Stock
2013-08-06
4
M
0
6500
17.54
A
77975
D
Common Stock
2013-08-06
4
S
0
6500
50.8026
D
71475
D
Common Stock
25006
I
Emerald Isle Trust
Common Stock
25006
I
Whitehall Trust
Stock Option (Right-to-Buy)
17.54
2013-08-06
4
M
0
6500
0
D
2018-03-19
Common Stock
6500
27096
D
Amount includes 62,500 shares held by IPC Living Trust of which Adam D. Singer, M.D. is the sole beneficiary and sole trustee and 8,975 shares of Common Stock subject to unvested Restricted Stock Grant.
Shares held by Emerald Isle Trust of which Adam D. Singer, M.D. is trustee.
Shares held by Whitehall Trust of which Adam D. Singer, M.D. is trustee.
The option execise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2012.
Options were granted on March 19, 2008. 25% of the options vest twelve months after the anniversary of the grant date. The remainder will vest in equal amounts monthly over the subsequent 36 months.
/s/ Fernando Sarria, attorney-in-fact
2013-08-07